Strategies for Identifying and Recruiting Women at High Risk forBreast Cancer for Research Outside of Clinical Settings:Observational Study

被引:0
作者
Conley, Claire C. [1 ]
Rodriguez, Jennifer D. [1 ]
McIntyre, McKenzie [2 ]
Niell, Bethany L. [3 ,4 ]
ONeill, Suzanne C. [1 ]
Vadaparampil, Susan T. [2 ]
机构
[1] Georgetown Univ, Dept Oncol, 2115 Wisconsin Ave NW,Suite 300, Washington, DC 20007 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Hlth Outcomes & Behav Program, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Diagnost Imaging & Intervent Radiol, Tampa, FL USA
[4] Univ S Florida, Dept Oncol Sci, Tampa, FL USA
关键词
breast cancer; high-risk populations; risk management; recruitment; woman; women; high risk; observational study; cross-sectional; Facebook; Twitter; flyer; flyers; community events; community event; genetic mutation; BREAST-CANCER; MRI;
D O I
10.2196/54450
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Research is needed to understand and address barriers to risk management for women at high (>= 20% lifetime)risk for breast cancer, but recruiting this population for research studies is challenging. Objective: This paper compares a variety of recruitment strategies used for a cross-sectional, observational study of high-risk women. Methods: Eligible participants were assigned female at birth, aged 25-85 years, English-speaking, living in the United States, and at high risk for breast cancer as defined by the American College of Radiology. Individuals were excluded if they had a personal history of breast cancer, prior bilateral mastectomy, medical contraindications for magnetic resonance imaging, or were not up-to-date on screening mammography per American College of Radiology guidelines. Participants were recruited from August 2020 to January 2021 using the following mechanisms: targeted Facebook advertisements, Twitter posts, Research Match(a web-based research recruitment database), community partner promotions, paper flyers, and community outreach events. Interested individuals were directed to a secure website with eligibility screening questions. Participants self-reported method ofrecruitment during the eligibility screening. For each recruitment strategy, we calculated the rate of eligible respondents andcompleted surveys, costs per eligible participant, and participant demographics. Results: We received 1566 unique responses to the eligibility screener. Participants most often reported recruitment via Facebookadvertisements (724/1566, 46%) and ResearchMatch (646/1566, 41%). Community partner promotions resulted in the highestproportion of eligible respondents (24/46, 52%), while ResearchMatch had the lowest proportion of eligible respondents (73/646,11%). Word of mouth was the most cost-effective recruitment strategy (US $4.66 per completed survey response) and paper flyers were the least cost-effective (US $1448.13 per completed survey response). The demographic characteristics of eligible respondents varied by recruitment strategy: Twitter posts and community outreach events resulted in the highest proportion of Hispanic or Latina women (1/4, 25% and 2/6, 33%, respectively), and community partner promotions resulted in the highest proportion of non-Hispanic Black women (4/24, 17%). Conclusions: Although recruitment strategies varied in their yield of study participants, results overall support the feasibility of identifying and recruiting women at high risk for breast cancer outside of clinical settings. Researchers must balance the associated costs and participant yield of various recruitment strategies in planning future studies focused on high-risk women.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Economic modeling of risk-adapted screen-and-treat strategies in women at high risk for breast or ovarian cancer
    Mueller, Dirk
    Danner, Marion
    Schmutzler, Rita
    Engel, Christoph
    Wassermann, Kirsten
    Stollenwerk, Bjoern
    Stock, Stephanie
    Rhiem, Kerstin
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2019, 20 (05) : 739 - 750
  • [32] A qualitative study on acceptable levels of risk for pregnant women in clinical research
    van der Zande, Indira S. E.
    van der Graaf, Rieke
    Oudijk, Martijn A.
    van Delden, Johannes J. M.
    BMC MEDICAL ETHICS, 2017, 18
  • [33] Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy
    Scott, CI
    Iorgulescu, DG
    Thorne, HJ
    Henderson, MA
    Phillips, KA
    CLINICAL GENETICS, 2003, 64 (02) : 111 - 121
  • [34] Recruiting, Linking, and Retaining High-Risk Transgender Women Into HIV Prevention and Care Services: An Overview of Barriers, Strategies, and Lessons Learned
    Reback, Cathy J.
    Ferlito, Dahlia
    Kisler, Kimberly A.
    Fletcher, Jesse B.
    INTERNATIONAL JOURNAL OF TRANSGENDERISM, 2015, 16 (04): : 209 - 221
  • [35] Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study
    Atci, Muhammed Mustafa
    Geredeli, Caglayan
    Ay, Seval
    Sakin, Abdullah
    Erturk, Biray
    Secmeler, Saban
    Arici, Serdar
    Cekin, Ruhper
    Yasar, Nurgul
    Can, Orcun
    Cihan, Sener
    Gumus, Mahmut
    EUROPEAN JOURNAL OF BREAST HEALTH, 2021, 17 (02) : 123 - 127
  • [36] A PRELIMINARY STUDY OF RISK FACTORS OF BREAST CANCER AND THE USEFULNESS OF BREAST MRI AS AN ADDITION TO MAMMOGRAPHY IN DETECTING BREAST CANCER IN HIGH RISK WOMEN
    Karim, Noor Khairiah A.
    Hami, Rohayu
    Hashim, Nur Hashamimi
    Azman, Nizuwan
    Shuaib, Ibrahim Lutfi
    JURNAL TEKNOLOGI, 2016, 78 (11-3): : 27 - 34
  • [37] Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials
    Monami, Matteo
    Filippi, Luca
    Ungar, Andrea
    Sgrilli, Federica
    Antenore, Alessandro
    Dicembrini, Ilaria
    Bagnoli, Paola
    Marchionni, Niccolo
    Rotella, Carlo Maria
    Mannucci, Edoardo
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (04) : 369 - 378
  • [38] Colorectal Cancer in Relation to Postmenopausal Estrogen and Estrogen Plus Progestin in the Women's Health Initiative Clinical Trial and Observational Study
    Prentice, Ross L.
    Pettinger, Mary
    Beresford, Shirley A. A.
    Wactawski-Wende, Jean
    Hubbell, F. Allan
    Stefanick, Marcia L.
    Chlebowski, Rowan T.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (05) : 1531 - 1537
  • [39] Observational study of the development and evaluation of a fertility preservation patient decision aid for teenage and adult women diagnosed with cancer: the Cancer, Fertility and Me research protocol
    Jones, G. L.
    Hughes, J.
    Mahmoodi, N.
    Greenfield, D.
    Brauten-Smith, G.
    Skull, J.
    Gath, J.
    Yeomanson, D.
    Baskind, E.
    Snowden, J. A.
    Jacques, R. M.
    Velikova, G.
    Collins, K.
    Stark, D.
    Phillips, R.
    Lane, S.
    Bekker, H. L.
    BMJ OPEN, 2017, 7 (03):
  • [40] Under-representation of Women in High-impact Published Clinical Cancer Research
    Jagsi, Reshma
    Motomura, Amy R.
    Amarnath, Sudha
    Jankovic, Aleksandra
    Sheets, Nathan
    Ubel, Peter A.
    CANCER, 2009, 115 (14) : 3293 - 3301